Cardiac amyloidosis and transplantation
A Heidelberg study of 115 patients suggests that heart transplantation has become a feasible option for some people with end-stage cardiac amyloidosis.
Newsroom
April 2023
-
-
First ever Canadian specific ATTR patient summit
The first Canadian ATTR Patient Summit brings together patients, families, physicians and industry in Toronto in April 2023 to share knowledge and experience.
-
The Australian Amyloidosis Workshops: A Platform for Scientific Advancement
Since 2014, the Australian Amyloidosis Workshops have brought together researchers, clinicians and patients to improve care for all types of amyloidosis.
-
What is a clinical trial ?
What is a clinical trial, why does it matter and is taking part voluntary? Answers to these questions and a short quiz to test your knowledge.
-
The Amyloidosis infographic
Four types of amyloidosis, four years before diagnosis, four specialists seen on average: an infographic to help raise awareness of amyloidosis.
-
READ AMY’S DISEASE STORY , diagnosed at 52
Amy was diagnosed with amyloidosis at 52, after years of unexplained symptoms. She shares her journey and why finding a specialist doctor matters.